Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma

The Journal of Pathology ◽

10.1002/path.4305 ◽

2014 ◽

Vol 232 (4) ◽

pp. 386-390 ◽

Author(s):

Maria M Caffarel ◽

Nicholas Coleman

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Therapeutic Target ◽

Cervical Squamous Cell Carcinoma ◽

Oncostatin M ◽

Oncostatin M Receptor ◽

Novel Therapeutic

Download Full-text

Abstract 4383: Transglutaminase-2 mediates the pro-malignant effects of oncostatin-M receptor overexpression in cervical squamous cell carcinoma.

10.1158/1538-7445.am2013-4383 ◽

2013 ◽

Author(s):

Maria M. Caffarel ◽

Anasuya Chattopadhyay ◽

Cinzia G. Scarpini ◽

Nicholas Coleman

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Transglutaminase 2 ◽

Cervical Squamous Cell Carcinoma ◽

Oncostatin M ◽

Oncostatin M Receptor

Download Full-text

Tissue transglutaminase mediates the pro‐malignant effects of oncostatin M receptor over‐expression in cervical squamous cell carcinoma

The Journal of Pathology ◽

10.1002/path.4222 ◽

2013 ◽

Vol 231 (2) ◽

pp. 168-179 ◽

Author(s):

Maria M Caffarel ◽

Anasuya Chattopadhyay ◽

Angela M Araujo ◽

Julien Bauer ◽

Cinzia G Scarpini ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Tissue Transglutaminase ◽

Cervical Squamous Cell Carcinoma ◽

Oncostatin M ◽

Over Expression ◽

Oncostatin M Receptor

Download Full-text

Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness

The Journal of Pathology ◽

10.1002/path.2968 ◽

2011 ◽

Vol 225 (3) ◽

pp. 448-462 ◽

Author(s):

David M Winder ◽

Anasuya Chattopadhyay ◽

Balaji Muralidhar ◽

Julien Bauer ◽

William R English ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Motility ◽

Cell Carcinoma ◽

Squamous Cell ◽

Cervical Squamous Cell Carcinoma ◽

Carcinoma Cells ◽

Oncostatin M ◽

Oncostatin M Receptor

Download Full-text

Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial–mesenchymal transition and poor overall survival

British Journal of Cancer ◽

10.1038/bjc.2016.199 ◽

2016 ◽

Vol 115 (2) ◽

pp. 212-222 ◽

Author(s):

Justyna A Kucia-Tran ◽

Valtteri Tulkki ◽

Stephen Smith ◽

Cinzia G Scarpini ◽

Katherine Hughes ◽

...

Keyword(s):

Overall Survival ◽

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Epithelial Mesenchymal Transition ◽

Cervical Squamous Cell Carcinoma ◽

Oncostatin M ◽

Poor Overall Survival ◽

Mesenchymal Transition ◽

Oncostatin M Receptor

Download Full-text

Gain and overexpression of the oncostatin M receptor occur frequently in cervical squamous cell carcinoma and are associated with adverse clinical outcome

The Journal of Pathology ◽

10.1002/path.2184 ◽

2007 ◽

Vol 212 (3) ◽

pp. 325-334 ◽

Author(s):

G Ng ◽

D Winder ◽

B Muralidhar ◽

E Gooding ◽

I Roberts ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Clinical Outcome ◽

Cell Carcinoma ◽

Squamous Cell ◽

Cervical Squamous Cell Carcinoma ◽

Oncostatin M ◽

Adverse Clinical Outcome ◽

Oncostatin M Receptor

Download Full-text

EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target

British Journal of Cancer ◽

10.1038/bjc.2011.222 ◽

2011 ◽

Vol 105 (3) ◽

pp. 420-427 ◽

Author(s):

K Iida ◽

K Nakayama ◽

M T Rahman ◽

M Rahman ◽

M Ishikawa ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Clinical Outcomes ◽

Gene Amplification ◽

Squamous Cell ◽

Therapeutic Target ◽

Cervical Squamous Cell Carcinoma ◽

Egfr Gene ◽

Novel Therapeutic

Download Full-text

2880 Immunohistochemical analysis of CD70 expression in 95 cases of squamous cell carcinoma of the head and neck: Correlation with clinicopathological variables and identification of a novel therapeutic target

European Journal of Cancer ◽

10.1016/s0959-8049(16)31617-3 ◽

2015 ◽

Vol 51 ◽

pp. S583-S584

Author(s):

A. De Meulenaere ◽

T. Vermassen ◽

S. Aspeslagh ◽

P. Deron ◽

F. Duprez ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Therapeutic Target ◽

Immunohistochemical Analysis ◽

Clinicopathological Variables ◽

Novel Therapeutic

Download Full-text

Depleted Tumor Suppressor miR-655 in Plasma Contributes to Poor Outcomes and Is a Novel Therapeutic Target in Esophageal Squamous Cell Carcinoma

Journal of the American College of Surgeons ◽

10.1016/j.jamcollsurg.2017.07.430 ◽

2017 ◽

Vol 225 (4) ◽

pp. S189

Author(s):

Jun Kiuchi ◽

Shuhei Komatsu ◽

Daisuke Ichikawa ◽

Taisuke Imamura ◽

Toshiyuki Kosuga ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Tumor Suppressor ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Therapeutic Target ◽

Poor Outcomes ◽

Novel Therapeutic

Download Full-text

Integrin alpha 6: A novel therapeutic target in esophageal squamous cell carcinoma

International Journal of Oncology ◽

10.3892/ijo.2013.2097 ◽

2013 ◽

Vol 43 (5) ◽

pp. 1523-1530 ◽

Author(s):

JUNHYE KWON ◽

TAE-SUP LEE ◽

HAE WON LEE ◽

MOON CHUL KANG ◽

HYEON-JOON YOON ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Therapeutic Target ◽

Integrin Alpha 6 ◽

Novel Therapeutic

Download Full-text

NEDD8-conjugating enzyme UBC12 as a novel therapeutic target in esophageal squamous cell carcinoma

Signal Transduction and Targeted Therapy ◽

10.1038/s41392-020-00226-3 ◽

2020 ◽

Vol 5 (1) ◽

Author(s):

Shiwen Wang ◽

Jingrong Xian ◽

Lihui Li ◽

Yanyu Jiang ◽

Yue Liu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Therapeutic Target ◽

Novel Therapeutic ◽

Conjugating Enzyme

Download Full-text